Header Logo

Jeffrey Marx

Concepts (125)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ophthalmology
3
2018
23
1.200
Why?
Angiogenesis Inhibitors
3
2016
78
0.920
Why?
Triamcinolone Acetonide
3
2009
13
0.610
Why?
Musculoskeletal Diseases
2
2012
101
0.580
Why?
Endophthalmitis
2
2015
11
0.560
Why?
Glucocorticoids
3
2009
172
0.540
Why?
Occupational Diseases
2
2012
266
0.530
Why?
Patient Satisfaction
2
2021
419
0.510
Why?
Anterior Eye Segment
1
2015
6
0.490
Why?
Physician-Patient Relations
1
2018
395
0.460
Why?
Retinal Vein Occlusion
4
2015
18
0.460
Why?
Diabetic Retinopathy
1
2015
45
0.460
Why?
Vascular Endothelial Growth Factor A
2
2016
201
0.460
Why?
Macular Degeneration
3
2011
179
0.420
Why?
Optometry
1
2012
8
0.390
Why?
Physicians, Family
1
2012
75
0.370
Why?
Macular Edema
3
2015
24
0.370
Why?
Eye Pain
1
2011
4
0.370
Why?
Anesthesia, Local
1
2011
20
0.370
Why?
Photochemotherapy
2
2008
20
0.360
Why?
Choroidal Neovascularization
2
2008
29
0.360
Why?
Anesthetics, Local
1
2011
69
0.350
Why?
Ranibizumab
3
2016
20
0.340
Why?
Visual Field Tests
1
2009
22
0.330
Why?
Hydroxychloroquine
1
2009
21
0.330
Why?
Retinal Diseases
1
2009
31
0.320
Why?
Visual Acuity
6
2016
118
0.300
Why?
Uveomeningoencephalitic Syndrome
1
2008
3
0.300
Why?
Vascular Neoplasms
1
2008
15
0.300
Why?
Peripheral Vascular Diseases
1
2008
45
0.290
Why?
Choroid
1
2008
26
0.290
Why?
Lymphoma
1
2008
100
0.280
Why?
Fluorescein Angiography
5
2008
58
0.280
Why?
Antirheumatic Agents
1
2009
214
0.270
Why?
Receptors, Vascular Endothelial Growth Factor
2
2016
33
0.250
Why?
Wet Macular Degeneration
2
2016
26
0.240
Why?
Vitreous Body
4
2011
31
0.240
Why?
Intravitreal Injections
3
2016
49
0.240
Why?
Neck Pain
1
2005
18
0.240
Why?
Eye
1
2004
54
0.230
Why?
Back Pain
1
2005
51
0.230
Why?
Angioplasty, Balloon
1
2004
58
0.230
Why?
Carotid Artery, Internal
1
2004
66
0.230
Why?
Male
14
2018
27987
0.220
Why?
Recombinant Fusion Proteins
2
2016
497
0.220
Why?
Carotid Stenosis
1
2004
105
0.210
Why?
Bevacizumab
2
2015
58
0.210
Why?
Ischemia
1
2004
195
0.210
Why?
Aged, 80 and over
7
2016
5202
0.180
Why?
Antibodies, Monoclonal, Humanized
2
2015
225
0.180
Why?
Stents
1
2004
459
0.180
Why?
Female
11
2018
31257
0.180
Why?
Aged
8
2018
13599
0.170
Why?
Middle Aged
8
2018
16552
0.160
Why?
Humans
16
2021
60164
0.160
Why?
Retina
3
2021
119
0.150
Why?
Injections
3
2009
80
0.150
Why?
Consumer Behavior
1
2018
35
0.150
Why?
Porphyrins
2
2008
7
0.150
Why?
Photosensitizing Agents
2
2008
14
0.140
Why?
Trust
1
2018
69
0.140
Why?
Health Care Surveys
1
2018
281
0.140
Why?
Prospective Studies
3
2015
3132
0.140
Why?
Subretinal Fluid
1
2016
3
0.130
Why?
Telemedicine
1
2021
337
0.130
Why?
Double-Blind Method
3
2016
684
0.120
Why?
Photometry
1
2015
7
0.120
Why?
Antibodies, Monoclonal
2
2011
854
0.120
Why?
Quality of Health Care
1
2018
524
0.110
Why?
Homocysteine
2
2005
57
0.110
Why?
Practice Patterns, Physicians'
1
2018
719
0.100
Why?
Tetracaine
1
2011
7
0.090
Why?
Propoxycaine
1
2011
5
0.090
Why?
Retrospective Studies
4
2009
6147
0.090
Why?
Lidocaine
1
2011
28
0.090
Why?
Cross-Sectional Studies
1
2018
2507
0.090
Why?
Surveys and Questionnaires
1
2018
2615
0.080
Why?
Drug Therapy, Combination
2
2008
436
0.080
Why?
Pain Measurement
1
2011
338
0.080
Why?
Treatment Outcome
4
2009
5267
0.080
Why?
Arthritis
1
2009
50
0.080
Why?
Fovea Centralis
1
2009
17
0.080
Why?
Prednisolone
1
2008
8
0.080
Why?
Vincristine
1
2008
26
0.080
Why?
L-Lactate Dehydrogenase
1
2008
28
0.080
Why?
Cyclophosphamide
1
2008
71
0.070
Why?
Antibodies, Monoclonal, Murine-Derived
1
2008
59
0.070
Why?
Rituximab
1
2008
82
0.070
Why?
Doxorubicin
1
2008
99
0.070
Why?
Vision Disorders
1
2008
59
0.070
Why?
Blood Vessels
1
2008
61
0.070
Why?
Diclofenac
1
2007
4
0.070
Why?
Regional Blood Flow
1
2008
108
0.070
Why?
Biopsy
1
2008
376
0.070
Why?
Tomography, Optical Coherence
2
2009
208
0.070
Why?
Pilot Projects
1
2009
930
0.060
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2007
202
0.060
Why?
Diagnosis, Differential
1
2008
910
0.060
Why?
Skin
1
2008
357
0.060
Why?
Fluorescein
1
2005
13
0.060
Why?
Ophthalmic Artery
1
2004
6
0.060
Why?
Self Disclosure
1
2005
37
0.060
Why?
Blood Chemical Analysis
1
2005
22
0.060
Why?
United States
1
2018
7623
0.060
Why?
Ultrasonography, Doppler, Transcranial
1
2004
21
0.060
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2008
406
0.060
Why?
New England
1
2005
268
0.060
Why?
Diagnostic Errors
1
2005
98
0.060
Why?
Magnetic Resonance Angiography
1
2004
180
0.050
Why?
Health Surveys
1
2005
311
0.050
Why?
Hyperhomocysteinemia
1
2002
8
0.050
Why?
Health Personnel
1
2005
343
0.050
Why?
Prevalence
1
2005
1300
0.040
Why?
Risk Factors
2
2008
5091
0.040
Why?
Follow-Up Studies
2
2016
2363
0.040
Why?
Time Factors
1
2005
3623
0.030
Why?
Adult
3
2009
15989
0.030
Why?
Pandemics
1
2021
629
0.030
Why?
Drug Combinations
1
2016
138
0.030
Why?
Ophthalmic Solutions
1
2007
12
0.020
Why?
Administration, Topical
1
2007
52
0.020
Why?
Fluorescence Polarization Immunoassay
1
2005
4
0.020
Why?
Artifacts
1
2005
126
0.010
Why?
Case-Control Studies
1
2002
1066
0.010
Why?
Diabetes Mellitus
1
2002
538
0.010
Why?
Marx's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (125)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_